Evaluation of the Neuroprotective Effect of Thiopental and Its Effect on Serum NSE Level in Neurocritical Care Patients

AuthorSara Salarianen
AuthorMohammad Sistanizaden
AuthorSeyedBashir Mirtajanien
AuthorMir Mohammad Mirien
AuthorMehran Koucheken
OrcidSara Salarian [0000-0002-4544-8883]en
OrcidSeyedBashir Mirtajani [0000-0003-4373-1383]en
OrcidMehran Kouchek [0000-0002-2070-9856]en
Issued Date2023-06-30en
AbstractBackground: This study aimed to evaluate the neuroprotective effect of thiopental and its effect on serum NSE levels in neurocritical care patients. Materials and Methods: Patients were divided into two groups (intervention and control). Thiopental administration as the intervention was started at a dose of 3-6 mg/Kg every 30 minutes and continued until 0.3-3 mg/Kg/hour. Sedation with fentanyl and midazolam as control was also performed in 35 patients. After three days, thiopental was discontinued. On the fifth day, the desired indicators were compared between the two groups. Results: On the third and fifth days, patients in the intervention group had a greater drop in serum NSE levels (Pen
DOIhttps://doi.org/10.22037/jcma.v8i2.37916en
KeywordThiopentalen
KeywordNeuron specific enolase (NSE)en
Keywordneurocritical careen
KeywordICUen
PublisherBrieflandsen
TitleEvaluation of the Neuroprotective Effect of Thiopental and Its Effect on Serum NSE Level in Neurocritical Care Patientsen
TypeBrief Communicationsen

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
191208.pdf
Size:
563.06 KB
Format:
Adobe Portable Document Format
Description:
Article/s PDF